Welcome to this presentation on evolving self-sufficiency. We are pleased to have a diverse audience today, including both home users and healthcare practitioners. This gathering highlights one of the positive outcomes of our current global situation: the ability to connect and collaborate.
Today, we will explore how coMra therapy serves as a bridge, allowing us to unite in our approach to health. Our panel includes Arzhan Surazakov, Director of Research and Development at Radiant Life Technologies, who will cover the science and the nature of the current global crisis. He will be joined by Dr. Anna Classen, who will provide clinical insights, and we will conclude with a session on the practical applications of telemedicine, followed by a Q&A.
We are living in a unique time. When we look at the undercurrent of the current global crisis, we see it as a crisis of self-sufficiency. Whether we consider the progression of viral infections – where the immune system fails to remain self-sufficient – or the broader societal challenges where supply chains and resources are disrupted, the core issue is a lack of holistic self-sufficiency.
At Radiant Life Technologies, our work over the past two decades has been dedicated to building tools, technologies, and relationships that foster self-sufficiency. We define this as helping people help themselves. There are no shortcuts; this process must begin with our own personal health, extending to our families, our clients, and our communities. The need for holistic medical technology has never been greater, and the world is currently seeking tools for effective home-based self-care.
Telemedicine is not a new concept, but its application today is different because we now have coMra therapy. This tool empowers the individual at home while providing the practitioner with a non-invasive, energy-based modality to support their patients remotely.
Arzhan Surazakov shares his background as a researcher who previously co-founded a large restorative medicine center in Russia. After two years of managing that facility, he realized the necessity of reaching patients who could not physically visit a clinic. This realization led to the development of his book on coMra therapy and a shift toward telemedicine.
For practitioners, this approach offers several advantages: * Accessibility: You can reach clients who are currently confined to their homes. * Inclusivity: You can connect with individuals who might not have previously considered holistic, non-invasive treatments but are now seeking solutions. * Systemic Support: Because coMra therapy is holistic – treating the whole system rather than just a symptom – it is an ideal tool for addressing complex conditions like diabetes or arthritis, which are often comorbid with other health challenges. * Safety: Telemedicine allows practitioners to continue their work safely, without the risk of viral transmission.
When addressing the current pandemic, our treatment approach must be effective, home-based, and affordable. Based on data from the World Health Organization and various clinical studies, we have identified three key conclusions regarding COVID-19:
1. Diagnosis: The only certainty in identifying COVID-19 versus similar respiratory illnesses is through detecting unique sequences in the virus’s RNA. 2. Immunosuppression: COVID-19 is characterized by a rapid onset of an immunosuppressed state within the first seven to ten days. In cases of pre-existing immunodeficiency, the disease progresses rapidly to pneumonia and critical stages. 3. Immune Support: The most effective way forward is to support the immune system. Vaccines, while necessary, are inevitably delayed, and the problem cannot be solved by financial measures or hospital capacity alone. We must focus on the body’s internal resources.
A study from an Ohio hospital involving 452 patients concluded that the novel coronavirus acts primarily on the immune system, specifically targeting T lymphocytes. Another study comparing 163 adults found that those confirmed with COVID-19 exhibited significantly higher levels of lymphopenia (low lymphocyte count) compared to those with seasonal influenza.
To understand why some individuals are more susceptible to severe outcomes, we must look at the body’s energy budget. Inflammation is an enormous energy load; mild inflammation consumes 25% of the body’s energy, while severe immune challenges like sepsis can consume up to 60%. When a person is already dealing with chronic conditions, pain, or psychological stress, their energy reserves are severely depleted.
If the body is in a constant state of "fight-or-flight" due to fear or anxiety, the immune system is effectively shut down. To be healthy, we must stop the leakage of our energy reserves and build up our functional reserves.
coMra therapy – which combines low-level laser, magnetic fields, ultrasound, and color LEDs – enhances the ability of cells to function. Our goal is to boost the body’s functional reserves before infection occurs.
Clinical research supports the use of low-level laser therapy in this context. For instance, studies on pneumonia have shown that non-invasive blood irradiation significantly increases the number and functional activity of T lymphocytes and neutrophils. In patients with moderate to severe inflammation, adding low-level laser therapy to standard care has been shown to nearly double the functional activity of neutrophils, leading to faster recovery and less severe symptoms.
We invite you to explore these concepts further in the book coMra Therapy: Healing with Coherence, which provides a comprehensive overview of how these technologies can be applied in a medical and home-care context. By empowering ourselves and our patients with these tools, we can move toward a more resilient and self-sufficient future.